These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 20197605)

  • 1. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
    Nauli SM; Rossetti S; Kolb RJ; Alenghat FJ; Consugar MB; Harris PC; Ingber DE; Loghman-Adham M; Zhou J
    J Am Soc Nephrol; 2006 Apr; 17(4):1015-25. PubMed ID: 16565258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystins, calcium signaling, and human diseases.
    Delmas P; Padilla F; Osorio N; Coste B; Raoux M; Crest M
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1374-83. PubMed ID: 15336986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
    Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
    J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cystogenesis: the search for drugs antagonizing cyst development.
    Ibraghimov-Beskrovnaya O; Bukanov NO
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S109-14. PubMed ID: 17373209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
    Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
    Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystins: what polycystic kidney disease tells us about sperm.
    Kierszenbaum AL
    Mol Reprod Dev; 2004 Apr; 67(4):385-8. PubMed ID: 14991728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
    Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
    Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARPKD and ADPKD: first cousins or more distant relatives?
    Kaimori JY; Germino GG
    J Am Soc Nephrol; 2008 Mar; 19(3):416-8. PubMed ID: 18272839
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus.
    Ha K; Nobuhara M; Wang Q; Walker RV; Qian F; Schartner C; Cao E; Delling M
    Elife; 2020 Nov; 9():. PubMed ID: 33164752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins.
    Xu T; Chen M; Xu Q; Xue C; Fu L; Ling K; Hu J; Mei C
    Front Biosci (Landmark Ed); 2022 Jul; 27(7):216. PubMed ID: 35866397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.
    Nauli SM; Alenghat FJ; Luo Y; Williams E; Vassilev P; Li X; Elia AE; Lu W; Brown EM; Quinn SJ; Ingber DE; Zhou J
    Nat Genet; 2003 Feb; 33(2):129-37. PubMed ID: 12514735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
    Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
    J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.